Previous 10 | Next 10 |
home / stock / thrbf / thrbf news
Developer of the AcuVidTM COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, Therma Bright ([[THRBF]] +13.7%) enters business agreement with Ridge Global, the consultancy founded by Governor Tom Ridge, the first U.S. S...
Toronto, Ontario--(Newsfile Corp. - March 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid TM COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announces that it has entered into business agreem...
Therma Bright (THRBF) announces that it has entered into an agreement with Safetest Diagnósticos of Brazil in partnership with the Federal University of Minas Gerais to conduct a clinical performance study of its AcuVid COVID-19 Rapid Saliva-based Antigen T...
Toronto, Ontario--(Newsfile Corp. - March 18, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has entered into an agreement with Safetest Diagnósticos("Safetest") of Brazil in partnership ...
Toronto, Ontario--(Newsfile Corp. - March 11, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has submitted an application to an independent Research Ethics Board ("REB") for approval to conduc...
Therma Bright (THRBF) announces that it has entered into an agreement with a COVID-19 testing site located in the Greater Toronto Area to conduct a clinical study with the company's AcuVid rapid antigen test for detecting SARS-CoV-2 virus in saliva.The testing site will allow T...
Toronto, Ontario--(Newsfile Corp. - February 26, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has entered into an agreement with a COVID-19 testing site located in the Greater Toronto Area t...
Toronto, Ontario--(Newsfile Corp. - January 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that in the past month, investors have exercised a total of 7,582,500 warrants and options to add $1,171,...
Therma Bright (THRBF) has taken 100% control of the research and development, regulatory, manufacturing and commercialization of its saliva-based rapid antigen test, as a result, the company will retain 100% of all future revenue and profits from the sale of the test.Therma Bright previously ...
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company announces that it has taken 100% control of the research and development, regulatory, manufacturing and commercialization ...
News, Short Squeeze, Breakout and More Instantly...
Therma Bright Inc. Company Name:
THRBF Stock Symbol:
OTCMKTS Market:
Company To Begin Embedding Solution Onto Each 15-Minute COVID-19 Rapid Antigen Test Cartridge Toronto, Ontario--(Newsfile Corp. - August 5, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company") , developer of its 'smart-enabled' AcuVid™ COVID-19 Rapid Antigen Saliva Test...
Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it ha...
Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide an update o...